Boston Scientific to Acquire Nalu Medical for $533 Million to Enhance Chronic Pain Solutions

Latham & Watkins LLP represented Nalu Medical, Inc. in its acquisition by Boston Scientific Corporation, providing comprehensive legal support across various practice areas. Boston Scientific Corporation announced its definitive agreement to acquire Nalu Medical, Inc., a medical technology company specializing in innovative solutions for chronic pain management. The transaction involves an upfront cash payment of approximately US$533 million for the remaining equity not owned by Boston Scientific, which has been a strategic investor in Nalu Medical since 2017. The legal team from Latham & Watkins LLP included Boston partner Hans Brigham and associate Laki Triantafylidis, along with Jennifer Boyd, Sue Kim, and Cherrie Wang. Additional support was provided by Orange County/Bay Area partners Shayne Kennedy and Ross McAloon, with associates Jacob Walsh, Kennedy Holmes, and Tony Noh on capital markets matters; Los Angeles partner Eric Cho and associate Grace Jang on tax matters; San Diego partner Holly Bauer and Orange County counsel Sara Schlau, with associate Iryna Onyshchenko on compensation and benefits matters; Washington, D.C. counsel Nicole Liffrig Molife and associate Megan Lich on healthcare regulatory matters; Washington, D.C. partner Nathan Beaton and associates Maya Frost-Belansky and Trevor Thompson on FDA matters; San Diego counsel Robert Yeh and associate Kristina Funahashi on intellectual property matters; Washington, D.C. partner Marissa Boynton and associate Kathryn Parsons-Reponte on data privacy and cybersecurity matters; Washington, D.C. partners Mandy Reeves and Patrick English, with associate Nathaniel Amann on antitrust matters; and associates Eduard Grigoryan and Emma Mayberry on emerging company and growth matters.

Boston Scientific to Acquire Nalu Medical for $533 Million to Enhance Chronic Pain Solutions

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads